Similar articles

• Lack of effect of percutaneous transluminal renal angioplasty on nocturnal hypotension in renovascular hypertensive patients.

  Ravogli A, Arzilli F, Omboni S, Giovannetti R, Mutti E, Salvetti A, Mancia G. Ravogli A, et al. J Hypertens. 1996 Jan;14(1):53-6. J Hypertens. 1996. PMID: 12013495
• [The clinical profiles of 78 patients with renovascular hypertension].

  Kudo K, Abe K, Yasujima M, Seino M, Sato M, Omata K, Hiwatari M, Kanazawa M, Yoshinaga K. Kudo K, et al. Nihon Naika Gakkai Zasshi. 1989 Apr;78(4):493-9. Nihon Naika Gakkai Zasshi. 1989. PMID: 2526191 Japanese. No abstract available.
• [The pathogenesis and treatment of renovascular hypertension].

  Kusano E, Akai Y. Kusano E, et al. Nihon Rinsho. 1989 Sep;47(9):2008-12. Nihon Rinsho. 1989. PMID: 2574241 Japanese. No abstract available.
• [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].

  Alhadad A, Sterner G, Herlitz H. Alhadad A, et al. Lakartidningen. 2009 Oct 28-Nov 3;106(44):2836-8, 2840. Lakartidningen. 2009. PMID: 19967962 Review. Swedish. No abstract available.
• Medical and non-medical approaches to renovascular hypertension.

  Spitalewitz S, Weber MA, Reiser IW. Spitalewitz S, et al. Cardiologia. 1997 Mar;42(3):237-43. Cardiologia. 1997. PMID: 9141238 Review. No abstract available.